Project Number 1RF1AG057547-01 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Prevention of Alzheimers disease in women: risks and benefits of hormone therapy Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 12. Neuroendocrine Mechanisms a. Sex Hormones Researcher and Organization Principal Investigator KANTARCI, KEJAL Principal Investigator First Name KEJAL Principal Investigator Last Name KANTARCI Awardee Organization MAYO CLINIC ROCHESTER Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-356: Major Opportunities for Research in Epidemiology of Alzheimer's Disease and Cognitive Resilience (R01) FY Overall Cost $10,638,873 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official ROBERTS, LUCI Related Resources Clinical Trial The Kronos Early Estrogen Prevention Study (KEEPS)
